IL6 and Orofacial dyskinesia: Although rodent studies are somewhat inconsistent, all but two in mice (Sonego et al., 2018, 2021) reported increased striatal IL-6 levels in haloperidol (Peroza et al., 2016; Datta et al., 2016; Mezzomo et al., 2022)-induced or reserpine (Soung et al., 2018)-induced orofacial dyskinesia.